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770 | J. Mater. Chem. A, 2014, 2, 770–7Facile preparation of a nanostructured
functionalized catalytically active organosalt†
Ahmad Reza Moosavi-Zare,*a Mohammad Ali Zolﬁgol,*b Vahid Khakyzadeh,b
Christoph Bo¨ttcher,c Mohammad Hassan Beyzavi,d Abdolkarim Zare,e
Alireza Hasaninejadf and Rafael Luqueg
We report a novel nanostructured organosalt, based on sulfonic acid functionalized pyrazinium {[H-
pyrazine–SO3H]Cl2} that was synthesized and characterized by several techniques including Fourier
transform infrared (FT-IR) spectroscopy, X-ray diﬀraction (XRD), thermal gravimetric analysis (TGA),
diﬀerential thermal gravimetric (DTG) analysis, transmission electron microscopy (TEM), mass
spectrometry (MS), proton NMR (1H NMR), carbon-13 NMR (13C NMR) and also electron diﬀraction (ED)
patterns. Results proved that the unprecedented sulfonated pyrizinium organosalt is indeed
nanostructured and highly crystalline as supported by TEM, ED and XRD studies, having an average
nanoparticle size of 50 nm according to TEM micrographs. The novel nano-organocatalyst was proved
to be an eﬃcient catalyst in the synthesis of 1,2,4,5-tetrasubstituted imidazoles by a one-pot multi-
component condensation of benzil, a broad range of aldehydes, primary amines and ammonium acetate
at 90 C under solvent-free conditions.Introduction
The design and application of high performance catalysts in
synthetic organic protocols including metal-free organic mole-
cules (organocatalysts) and organometallic catalysts have
attracted a signicant amount of interest from the scientic
community in order to develop increasingly attractive method-
ologies for the preparation of more complex molecules.1 Orga-
nocatalysts have a signicant impact and direct benet in the
production of pharmaceutical intermediates when compared
with (transition) metal catalysts.
In addition, organocatalysts are commonly inexpensive,
stable and readily available, show low toxicity and no sensitivity
towards moisture or oxygen.2 Another advantage of organo-
catalysts relates to their favourable surface to volume ratioyyed Jamaleddin Asadabadi, Asadabad,
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77which enhances the contact between reactants and catalyst
support and in turn increases the catalytic activity.3 In spite of
their controversy as greener compounds, ionic liquids (ILs) can
be considered as organocatalysts.4 In this context, we have
recently reported a novel family of ionic liquids based on acidic
sulfonic acid functionalized imidazolium salts (SAFIS).5–14 S–N
bond formation yielding imidazole derivatives as a ve member
heterocyclic ring compound was reported for the rst time by
employing such acidic ILs as catalysts. Importantly, the catalytic
activities of these acidic-functionalized organocatalysts were
further extended to chemistries involving the preparation of
bis(indolyl)methanes,5 N-sulfonyl imines,6 nitro aromatic
compounds,7,8 1-amidoalkyl-2-naphthols,9 xanthenes,10 1-car-
bamatoalkyl-2-naphthols,11 4,40-(arylmethylene)-bis(3-methyl-1-
phenyl-1H-pyrazol-5-ol)s,12 tert-butyl aryl carbamates13 and
hexahydroquinolines.14
In continuation of previous research endeavours related to
the design and development of novel acidic functionalised ILs
and solid salts for organic transformations, we have now
prepared and characterized a novel nanostructured organosalt
(sulfonic acid pyrazinium chloride) (Scheme 1). The synthesized
organocatalyst was successfully employed in the synthesis of
diﬀerent poly-substituted imidazole derivatives exhibiting
various important properties (Scheme 2).
Imidazoles are one of the most important groups of ve
membered nitrogen heterocycles which have attracted much
attention because of their participation in the structure and
activity of biological molecules including histidine, histamine
or biotin.15 Importantly, there is high demand for theseThis journal is © The Royal Society of Chemistry 2014
Scheme 1 The preparation of sulfonic acid functionalized pyrazinium
salt {[H-pyrazine–SO3H]Cl2}.
Scheme 2 The preparation of 1,2,4,5-tetrasubstituted imidazoles (R
and Ar groups are given in Table 1).
Scheme 3 The preparation of sulfonic acid functionalized pyrazinium















































View Article Onlinecompounds from the pharmaceutical viewpoint and the imid-
azole moiety is the core structure of important drugs such as
losartan, olmesartan, eprosartan and trifenagrel (Fig. 1).16
Moreover, they are very popular as ILs17 and N-heterocyclic
carbenes (NHCs) in organometallic chemistry have been
increased.18,19
Several catalytic methods have been reported to improve the
yields for the synthesis of polysubstituted imidazoles. Catalysts
employed in this process include heteropolyacids,20 silica gel
and zeolites,21 alumina,22 HClO4–SiO2,23 I2,24 BF3$SiO2,25
InCl3$3H2O,26 K5CoW12O40$3H2O,27 copper acetate,28 or tri-
uoroacetic acid using microwave irradiation.29 Other examples
for the synthesis of polysubstituted imidazoles have also been
reported in the literature.30
However, most of the reported protocols have inherent
drawbacks related to laborious and complex reaction workup,
tedious purication steps, generation of signicant amounts
of waste, employment of strongly acidic conditions, side
reactions, poor yields and the use of expensive or sophisti-
cated catalysts. Comparatively, the utilization of the proposed
organosalt as a catalyst in the synthesis of substituted imid-
azoles can provide additional advantages in terms of reaction
eﬃciency, selectivity and the possibility of recycling the
catalyst for further use. To the best of our knowledge, this is
also the rst report of the preparation of a catalytically active
nanostructured organosalt.Fig. 1 The structure of a few exemplary drugs such as losartan, olmesart
This journal is © The Royal Society of Chemistry 2014Results and discussion
The expected di-sulfonic acid functionalized pyrazinium salt
{i.e. [SO3–pyrazine–SO3H]Cl2} was surprisingly not observed in
the synthesis of the sulfonic acid functionalized pyrazinium
salt, with mono-functionalized [H-pyrazine–SO3H]Cl2 as the
main product (Scheme 3).
Characterization of {[H-pyrazine–SO3H]Cl2} was carried out
using various analytical techniques including IR, 1H NMR, 13C
NMR and mass spectrometry.
The IR spectrum of the catalyst showed a broad peak at
2650–3500 cm1 which could contain the overlaid NH+Cl
stretching peak (2800 cm1, bs),31 and the O–H stretching of
SO3H. Moreover, the two peaks observed at 1069 cm
1 and 1174
cm1 correspond to vibrational modes of N–SO2 and O–SO2
bonds. Another peak at 1010 could be correlated with S]O
bonds (Fig. 2).
The important peak found in 1H NMR spectra of the catalyst
is related to the acidic hydrogen of SO3H which was observed at
13.23 ppm (Fig. 3b). 1H NMR spectra of ClSO3H (starting
material) as well as [H-pyrazine–H]Cl2 in DMSO {[H-pyrazine–H]
[ClSO3]2 was not commercially available and [H-pyrazine–H]Cl2
has the same type of acidic H environments} were run to further
conrm the presence of SO3H hydrogen in the catalyst (and not
to unreacted starting material or possible byproducts).
In these spectra, the peaks of the acidic hydrogens of
[H-pyrazine–SO3H]Cl2, ClSO3H and [H-pyrazine–H]Cl2 were
observed at 13.23, 10.75 and 9.25 ppm, respectively (Fig. 3a).
The diﬀerence between the peaks of the acidic hydrogens in
the compounds conrmed that the peak observed at 13.23an, eprosartan and trifenagrel, which incorporate an imidazole moiety.
salt {[H-pyrazine–SO3H]Cl2}.
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Fig. 2 IR spectrum of sulfonic acid functionalized pyrazinium salt {[H-pyrazine–SO3H]Cl2}.















































View Article Onlineppm of the 1H NMR spectra of [H-pyrazine–SO3H]Cl2 is
correctly related to the hydrogen of the SO3H-functionalized
pyrazinium salt.Fig. 3 (a) 1H NMR spectra of pyrazinium chloride {[H-pyrazine–H]Cl2};
(b) 1H NMR spectra of sulfonic acid functionalized pyrazinium salt
{[H-pyrazine–SO3H]Cl2}.
772 | J. Mater. Chem. A, 2014, 2, 770–777Results were also in good agreement with mass spectra of
[H-pyrazine–SO3H]Cl2, which indicated a parent peak of 233 m/
z, the expected mass of the catalyst (ESI†).
Another set of evidence of the structure of the catalyst was
obtained from 13C NMR spectra. Two peaks present at 144.26
and 150.75 support the proposed asymmetric structure of the
catalyst from Scheme 3 (Fig. 4).
XRD patterns of the catalyst {[H-pyrazine–SO3H]Cl2} were
investigated in a domain of 10–90 degrees (Fig. 5). As shown in
Fig. 5, the patterns exhibited diﬀraction lines of a highly
crystalline structure at 2q z 14.48, 16.97, 18.50, 18.80,
19.09, 22.38, 25.08, 26.03, 27.86, and 28.45, and several
small lines in the 30–60 range. Peak width (FWHM), size and
inter-planar distance studies of the catalyst could be worked
out in the 14.5 to 33. 3 degree range and the results are
summarized in Table 1. As an example, calculations for the
highest diﬀraction line 26.03 proved that an FWHM of 0.126,
a crystallite size of ca. 120 nm, calculated via the ScherrerFig. 4 13C NMR spectra of sulfonic acid functionalized pyrazolium salt
{[H-pyrazine–SO3H]Cl2}.
This journal is © The Royal Society of Chemistry 2014
Fig. 5 XRD pattern of the nanostructured organosalt.






1 14.50 0.212 54 0.610853
2 16.99 0.163 77 0.521848
3 18.79 0.258 43 0.472243
4 19.10 0.198 60 0.464649
5 22.41 0.146 93 0.396712
6 25.10 0.108 157 0.354771
7 26.01 0.126 119 0.342563
8 28.30 0.184 69 0.315343
9 33.30 0.152 93 0.269048
Fig. 7 TG/DTG plots of the [H-pyrazine–SO3H]Cl2.















































View Article Onlineequation [D ¼ Kl/(b cos q)], and an inter-planar distance of
0.343 nm (calculated using the Bragg equation: dhkl ¼ l/
(2 sin q), l: Cu radiation (0.154178 nm)) were obtained. Most
importantly, crystallite sizes as obtained from the various
diﬀraction lines using the Scherrer equation were found to be
in the nanometer range (50–160 nm), a most relevant nding
for the synthesized organosalt.
To further conrm the nanostructure of the synthesized
organosalt, TEM measurements were performed as depicted in
Fig. 6a.Fig. 6 (a) Transmission electron micrographs (TEM) of the catalyst partic
from (a); (c) electron diﬀraction (ED) patterns of the catalyst.
This journal is © The Royal Society of Chemistry 2014The TEM micrograph (Fig. 6a) conrmed the presence of
more or less spherical nanoparticles with a mean diameter of
51 nm (Fig. 6b, from the analysis of 307 particles via image
processing program of Fig. 6a). TEM imaging was com-
plemented by electron diﬀraction (ED) patterns (Fig. 6c) to
check the materials’ crystalline nature. The most prominent ED
rings corresponded to real spacings at 0.5219 nm, in good
agreement with XRD results (Table 1, entry 2). Additional
prominent diﬀraction rings could be observed at 0.438 nm (no
analogous value in XRD), 0.397 nm (Table 1, entry 5) and 0.317
nm (Table 1, entry 8). ED results further conrmed the nano-
scale nature of the synthesized organosalt.
The stability of the catalyst was further investigated by thermal
gravimetric (TG) and diﬀerential thermal gravimetric (DTG)
analyses. TG and DTG plots in Fig. 7 indicate that weight loss of
[H-pyrazine–SO3H]Cl2 occurred in a single step aer 280 C, so
that [H-pyrazine–SO3H]Cl2 is in principle stable up to 280 C. The
TG pattern coincides with a single stage decomposition of the
organosalt in which no additional intermediate was identied.
Upon detailed characterization and stability studies,
[H-pyrazine–SO3H]Cl2 was subsequently investigated as a cata-
lyst for organic transformations.les; (b) histogram of the size distribution of 307 catalyst particles taken
J. Mater. Chem. A, 2014, 2, 770–777 | 773















































View Article OnlineThe synthesis of polysubstituted imidazoles was selected as
the test reaction for the organocatalyst. Preliminary experi-
ments were aimed to screen and optimize reaction conditions
for the model reaction of benzil (1 mmol), 4-chlor-
obenzaldehyde (1 mmol), benzylamine (1 mmol) and ammo-
nium acetate (1 mmol) under mild temperature (80–95 C).
Results summarized in Fig. 8 pointed out that optimum results
were obtained using catalytic amounts (1 mol%) [H-pyrazine–
SO3H]Cl2 at 90 C. In principle, this reaction could be then
considered as solventless. The use of [H-pyrazine–H]Cl2 as well
as H2SO4 as alternative catalysts in the reaction provided
comparably lower yields to the target product under investi-
gated reaction conditions (Fig. 8).
Upon optimization of reaction conditions, the scope and
eﬃciency of the process were subsequently explored for a rangeFig. 8 Eﬀect of diﬀerent amounts of the catalyst loading and temperatu
ammonium acetate.
Table 2 The synthesis of 1,2,4,5-tetrasubstituted imidazoles using [H-p
Entry Ar R Ti
1a C6H5 C6H5 10
1b C6H5 C6H5CH2 15
1c 4-CH3–C6H4 C6H5 25
1d 4-CH3–C6H4 C6H5CH2 15
1e 4-Cl–C6H4 4-Cl–C6H4 10
1f 3-NO2–C6H4 4-CH3–C6H4 25
1g 4-NO2–C6H4 4-CH3–C6H4 15
1h 4-Cl–C6H4 C6H5CH2 10
1i 4-Cl–C6H4 4-F–C6H4 10
1j 4-CH3–C6H4 4-CH3–C6H4 15
1k 3-OCH3–C6H4 C6H5CH2 25
1l 4-Cl–C6H4 C6H5 10
1m 4-OH–C6H4 C6H5CH2 20
1n 4-OCH3–C6H4 C6H5CH2 15
1o 4-OH–C6H4 C6H5 15
1p 4-CN–C6H4 4-CH3–C6H4 15
1q 3-OH–C6H4 4-CH3–C6H4 15
1r 2-Thienyl 4-CH3–C6H4 25
1s 2-Thienyl 4-OH–C6H4 15
a 1H NMR and 13C NMR of products given in the ESI. b Yield of the puri
774 | J. Mater. Chem. A, 2014, 2, 770–777of structurally diversed aromatic aldehydes as well as amines
(aliphatic or aromatic). Gratifyingly, the proposed reaction cat-
alysed by the nanostructured organosalt was amenable to
several susbtrates under very mild reaction conditions and
short times of reaction (typically 90 C, Table 2).
A number of substituted imidazole products could be
obtained in good to excellent yields in the absence of byprod-
ucts under the investigated conditions.
The proposed catalytic routes are depicted in Scheme 4,
which are consistent with literature reports.14,19,32 The nano-
organosalt [H-pyrazine–SO3H]Cl2 has two acidic hydrogens
which can participate in hydrogen bonding. Consequently, both
aldehydes and benzil were activated by [H-pyrazine–SO3H]Cl2 to
accept nucleophiles. In particular, we believe that the diﬀer-
ences in acidity of the SO3H hydrogen from [H-pyrazine–SO3H]re on the reaction of benzil, 4-chlorobenzaldehyde, benzylamine and
yrazine–SO3H]Cl2 (1 mol%) under solvent-free conditions at 90 C
a
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Scheme 4 Proposed reaction mechanism for the synthesis of 1,2,4,5-
tetrasubstituted imidazoles using [H-pyrazine–SO3H]Cl2.















































View Article OnlineCl2 as compared to those of [H-pyrazine–H]Cl2 and H2SO4 may
account for the observed improved catalytic activity in Fig. 8. A
partial contribution of the nanocrystallinity of the organosalt
cannot be either ruled out but this (if any) would be in principle
expected to be not very signicant. Also, the formation of several
hydrogen bonds between substrates and catalyst could facilitate
a more eﬃcient catalysis in the reaction. High reaction rates
could also be inuenced by the organosalt nanostructure, which
will be investigated in due course.
The recovery and reuse of the catalyst was also examined for
the reactions of benzil, 4-chlorobenzaldehyde, benzylamine and
ammonium acetate by means of a hot ltration test.33 The
reaction mixture was ltered oﬀ half way through reaction,
extracted using hot absolute ethanol or ethyl acetate and sepa-
rated out from the catalyst. The reused catalyst upon ltration
was subsequently employed in another reaction run with fresh
reagents while the ltrate of the reaction mixture was le
reacting for several hours.
The catalytic activity of the nano-organocatalyst was found to
be almost preserved aer ve successive runs, with a slight
decrease in rate constant (by a factor of two, assuming a rst
order kinetics). Nevertheless, products were obtained in
excellent yield aer ve runs in a short time of reactionTable 3 Reuses of [H-pyrazine–SO3H]Cl2 in the reaction between
benzil, 4-chlorobenzaldehyde, benzylamine and ammonium acetate
at 90 C
Run 1 2 3 4 5
Time [min] 10 10 12 13 15
Yielda [%] 95 93 93 91 90
a Isolated yield.
This journal is © The Royal Society of Chemistry 2014(typically 10–15 min, Table 3). The analogous reaction from the
ltrate did not react further under similar reaction conditions
even aer 1 h reaction.
Conclusions
A novel nanostructured sulfonic acid functionalized pyrazinium
salt {[H-pyrazine–SO3H]Cl2} was synthesized, characterized and
tested as a reusable nano-organosalt in the one-pot four-
component reaction of aldehydes (hetero-aromatic and
aromatic aldehydes), amines (aliphatic or aromatic), benzil and
ammonium acetate under mild reaction conditions to give
1,2,4,5-tetrasubstituted imidazoles. Excellent features of the
proposed methodology include high eﬃciency, versatility, short
times of reaction, high yields to products, cleaner reaction
proles and simplicity, making it an attractive alternative for




All chemicals were purchased from Merck or Fluka Chemical
Companies. Known products were identied by comparison of
their melting points and spectral data with those in the
authentic samples. 1H NMR (500 MHz) and 13C NMR (125 MHz)
were run on a Bruker Avance DPX-250 FT-NMR spectrometer (d
in ppm). Melting points were recorded on a Bu¨chi B-545 appa-
ratus in open capillary tubes. The crystal structure of synthe-
sized materials was determined using an X-ray diﬀractometer
(Italstructure ADP2000 XRD) at ambient temperature. Mass
spectra were recorded on a Shimadzu GC MS-QP 1000 EX 85
apparatus. Thermal gravimetry (TG) and diﬀerential thermal 88
gravimetric (DTG) analysis were performed on a Perkin Elmer
Model: 89 Pyris 1. Transmission electron microscopy imaging
was carried out using a Tecnai F20 (FEI company, Oregon, USA)
with eld emission illumination operated at an acceleration
voltage of 160 kV.
Procedure for the preparation of sulfonic acid functionalized
pyrazinium salt {[H-pyrazine–SO3H]Cl2} (Scheme 3)
Chlorosulfonic acid (1.177 g, 10.2 mmol) was added dropwise
into a round-bottomed ask (50 mL) containing pyrazine (0.400
g, 5 mmol) in CH2Cl2 (20 mL) over a period of 30 min at room
temperature. Upon complete addition, the reaction mixture was
stirred and heated under reux conditions for 12 h. Upon
cooling down very slowly to room temperature, CH2Cl2 was
decanted. The solid residue was then washed with dry CH2Cl2
(3  20 mL) and dried under vacuum to give [H-pyrazine–SO3H]
Cl2 as gray solid powder in 98% yield, 1.14 g.
Procedure for the synthesis of 1,2,4,5-tetrasubstituted
imidazoles using [H-pyrazine–SO3H]Cl2 as catalyst (1a–s)
A mixture of benzil (1 mmol), aldehyde (1 mmol), primary
amine (1 mmol), ammonium acetate (1 mmol, as precursor for
the in situ generation of ammonia) and [H-pyrazine–SO3H]Cl2J. Mater. Chem. A, 2014, 2, 770–777 | 775















































View Article Online(1 mol%) in a 10 mL round-bottomed ask connected to a reux
condenser was stirred in an oil-bath at 90 C. Aer completion
of the reaction, as monitored by TLC, the mixture was cooled to
room temperature. Crude products were dissolved in warm
ethanol or warm ethyl acetate and separated oﬀ from the cata-
lyst, which was then ltered oﬀ. The remaining solid was
washed with ethyl acetate (5 mL) and dried under reduced
pressure ([H-pyrazine–SO3H]Cl2 was recovered in 95% yield).
Then, the pure product was obtained by the recrystallization of
the reaction mixture in ethanol or ethyl acetate.Characterization methods
Due to the radiation sensitivity of the organic material, the
diﬀraction spacings quickly faded upon irradiation. Low-dose
techniques implemented in the microscopes’ soware were
therefore used in order to allow for imaging of the diﬀraction data.
Thermal gravimetric analysis (TGA) of the sulfonic acid
functionalized pyrazinium salt was also studied in a range of 25
up to 800 C, with a temperature increase rate of 10 Cmin1 in
a nitrogen atmosphere (Fig. 8).
Samples for TEM were generally prepared by ultrasonication
of 10 mg solid in hexane for 30 minutes, which gave a turbid
suspension in all cases. The solid was treated beforehand in an
agate mortar for milling larger particles. Droplets of the
suspension were applied to carbon foil covered microscopical
400 mesh copper grids (BAL-TEC GmbH, Witten, Germany) and
dried in air. No additional staining materials were used. The
grids were consecutively transferred into a Tecnai F20 FEG
transmission electron microscope (FEI company, Oregon, USA)
operating at 160 kV acceleration voltage. Images were taken at
various magnications ranging from 2k up to 19k. Data were
recorded by the use of an Eagle 2k CCD camera (FEI company) at
full resolution (binning 1). The application of the microscopes’
low dose routine was necessary for image and diﬀraction pattern
recordings as the crystal ultrastructure turned out to suﬀer from
radiation damage. Diﬀraction patterns were recorded at a
camera length of 520 mm. Calibration was done using a thal-
lium chloride standard (Plano GmbH, Wetzlar, Germany).Acknowledgements
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